BRPI1007007A2 - cyclic peptides, nucleic acid molecule, vector, host cell, method for producing a cyclic peptide, pharmaceutical composition, method for detecting antibodies to a b-ar (in a sample) - Google Patents

cyclic peptides, nucleic acid molecule, vector, host cell, method for producing a cyclic peptide, pharmaceutical composition, method for detecting antibodies to a b-ar (in a sample)

Info

Publication number
BRPI1007007A2
BRPI1007007A2 BRPI1007007A BRPI1007007A BRPI1007007A2 BR PI1007007 A2 BRPI1007007 A2 BR PI1007007A2 BR PI1007007 A BRPI1007007 A BR PI1007007A BR PI1007007 A BRPI1007007 A BR PI1007007A BR PI1007007 A2 BRPI1007007 A2 BR PI1007007A2
Authority
BR
Brazil
Prior art keywords
vector
sample
producing
nucleic acid
pharmaceutical composition
Prior art date
Application number
BRPI1007007A
Other languages
Portuguese (pt)
Inventor
Hans-Richard Rackwitz
Martin J Lohse
Roland Jahns
Valérie Jahns
Original Assignee
Julius Maximilians Universität Würzburg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Julius Maximilians Universität Würzburg filed Critical Julius Maximilians Universität Würzburg
Publication of BRPI1007007A2 publication Critical patent/BRPI1007007A2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70571—Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Neurology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BRPI1007007A 2009-01-27 2010-01-27 cyclic peptides, nucleic acid molecule, vector, host cell, method for producing a cyclic peptide, pharmaceutical composition, method for detecting antibodies to a b-ar (in a sample) BRPI1007007A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20609109P 2009-01-27 2009-01-27
PCT/EP2010/050949 WO2010086337A1 (en) 2009-01-27 2010-01-27 Novel peptide-homologues for inhibiting beta1-adrenoceptor antibodies

Publications (1)

Publication Number Publication Date
BRPI1007007A2 true BRPI1007007A2 (en) 2016-03-22

Family

ID=42111643

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1007007A BRPI1007007A2 (en) 2009-01-27 2010-01-27 cyclic peptides, nucleic acid molecule, vector, host cell, method for producing a cyclic peptide, pharmaceutical composition, method for detecting antibodies to a b-ar (in a sample)

Country Status (4)

Country Link
EP (1) EP2391637A1 (en)
BR (1) BRPI1007007A2 (en)
MX (1) MX2011007882A (en)
WO (1) WO2010086337A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2452964C1 (en) * 2011-04-15 2012-06-10 Федеральное государственное учреждение "Российский кардиологический научно-производственный комплекс" Министерства здравоохранения и социального развития (ФГУ "РКНПК" Минздравсоцразвития России) METHOD OF IMMUNE-ENZYME ASSAY FOR DETECTING β1-ADRENORECEPTOR AUTOIMMUNE ANTIBODIES IN HUMAN BLOOD PLASMA AND SERUM
CN108218963B (en) * 2018-01-19 2020-10-13 首都医科大学 Cyclic peptide and preparation method and application thereof
US20240124594A1 (en) * 2021-02-02 2024-04-18 The Cleveland Clinic Foundation Treatment of cvd and systemic scerosis with beta-1 adrenergic receptor antibodies
IL310838A (en) * 2021-08-27 2024-04-01 Univ Yale Molecular degraders of extracellular proteins

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4880635B1 (en) 1984-08-08 1996-07-02 Liposome Company Dehydrated liposomes
JP2003514772A (en) * 1999-09-21 2003-04-22 アフィーナ イミュンテヒニク ゲゼルシャフト ミット ベシュレンクテル ハフツング Peptides against autoantibodies causing DCM
EP1536020A1 (en) 2003-11-26 2005-06-01 Bayerische Julius-Maximilians-Universität Würzburg Means and methods for optical determination of cAMP in vitro and in vivo
WO2006046589A1 (en) * 2004-10-28 2006-05-04 Kaneka Corporation ADSORBENT ADSORBING ANTIBODY AGAINST β1 ADRENORECEPTOR
US8187605B2 (en) 2005-03-31 2012-05-29 Julius-Maximillians-Universität Würzburg Means for the inhibition of anti-β1-adrenergic receptor antibodies
EP2497777A3 (en) * 2007-08-24 2012-10-10 Julius-Maximilians-Universität Würzburg Mutant double cyclized receptor peptides inhibiting beta 1-adrenoceptor antibodies

Also Published As

Publication number Publication date
WO2010086337A1 (en) 2010-08-05
EP2391637A1 (en) 2011-12-07
MX2011007882A (en) 2011-11-04

Similar Documents

Publication Publication Date Title
BR112012024287A2 (en) antibody, pharmaceutical composition, method, nucleic acid, expression vector and host cell
BR112012022046A2 (en) "antibody, pharmaceutical composition, nucleic acid, expression vectors, host cell and method for producing a recombinant antibody".
BRPI1014525A2 (en) precursor polypeptide variant, pharmaceutical composition, isolated nucleic acid, vector, host cell, method for producing a variant, medicament, and use of a variant
BR112014003598A2 (en) bispecific antigen binding molecule, isolated polynucleotide, expression vector, host cell, method for producing bispecific antigen binding molecule, pharmaceutical composition, use and method for treating a disease in an individual
BR112014000627A2 (en) Mitting polymerase polypeptide, fusion protein, nucleic acid molecule, vector, vector production process, host cell, method, composition, use and kit
BR112014022708A2 (en) Use of a p75ntr neurotrophin binding protein, use of a nucleic acid molecule, use of a replicable expression vector, host cell, pharmaceutical composition and kit
CL2015001709A1 (en) Peptide tag that binds to hyaluronan; nucleic acid encoding it; vector; host cell; molecule labeled with said peptide; composition that comprises it; and peptide tag production method.
BR112014012624A2 (en) antibodies, pharmaceutical composition, nucleic acid, expression vectors, host cell, method for producing a recombinant antibody and use of the antibody
BR112013033350A2 (en) immunocytocin, nucleic acid, vector, host cell and pharmaceutical composition
BRPI1015916A2 (en) Nucleic acid molecule, expression vector, host cell, as well as method for expression of a substitute light chain (slc) construct or an slc polypeptide
BRPI0922187A2 (en) vector composition, polynucleotide assembly kit, nucleic acid molecule library, methods for generating a polynucleotide, and a host cell, host cell, polynucleotide, and method for making a vector
BR112012031843A2 (en) peptide molecule, nucleic acid molecule, vector, host cell, peptide production method, composition, composition production method, peptide internalization behavior detection method, pharmaceutical composition, peptide use, method for prevention and / or treatment and parts kit
BR112012011740A2 (en) polypeptide, a composition comprising said polypeptide, protein complex, nucleotide sequence, cell expression vector, and methods for preparing the protein complex, for preparing a fviii, and for enhancing a plasma pharmacokinetic property of a fviii
EA201300074A1 (en) METHOD OF OBTAINING A REPRESENTATIVE INTEREST OF CONNECTION
BR112013018307A2 (en) isolated polypeptide, composition, isolated polynucleotide, nucleic acid construct or expression vector, recombinant host cell, methods for producing a polypeptide and a protein, and processes for degrading a cellulosic material, for synthesizing a fermentation product, and for fermenting a cellulosic material.
BR112014011137A2 (en) polynucleotide, vector, host cell, polypeptide, antibody, method for making a polypeptide, method for making a drug
SG11201403450VA (en) Artificial nucleic acid molecules for improved protein or peptide expression
BR112014001855A2 (en) antigen-binding construct and protein, dimer, pharmaceutical composition, polynucleotide sequence, host cell and method for construct production
BRPI0922106A2 (en) isolated monoclonal antibody, isolated nucleic acid molecule, host cell, method for producing an isolated monoclonal antibody, pharmaceutical composition, and use of the composition
BRPI0814781A2 (en) PROTEIN, NUCLEIC ACID SEQUENCE, METHOD FOR THE PRODUCTION OF ITAONIC ACID, VECTOR, HOST CELL, AND USE OF A CIS-ACONYTIC ACID
BR112013018695A2 (en) isolated polypeptides, enzyme composition, isolated polynucleotides, nucleic acid construct or expression vector, recombinant host cell, methods for producing a cellobiohydrole activity polypeptide, and a protein, and for fermenting a cellulosic material, and processes for degrading a cellulosic material, and to synthesize a fermentation product
WO2012129363A3 (en) Single cell nucleic acid detection and analysis
BR112012020372A8 (en) human csf-1r binding antibody, pharmaceutical composition, nucleic acid, expression vectors, host cell and method for producing a recombinant antibody
EP2583973A4 (en) Method for purifying protein using amino acid
BRPI0808104A2 (en) Methods for preparing and producing a polypeptide, polypeptide, isolated nucleic acid sequence, nucleic acid construct, recombinant expression vector, and recombinant host cell.

Legal Events

Date Code Title Description
B08F Application fees: dismissal - article 86 of industrial property law

Free format text: REFERENTE A 7A ANUIDADE.

B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2395 DE 29-11-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.